Neonatal Dendritic Cells and Antigen Processing
Author Information
Author(s): Gold Marielle C., Robinson Tammie L., Cook Matthew S., Byrd Laura K., Ehlinger Heather D., Lewinsohn David M., Lewinsohn Deborah A.
Primary Institution: Oregon Health & Science University
Hypothesis
The increased severity of disease associated with neonates is due to a defect in dendritic cell MHC I antigen processing and presentation.
Conclusion
Neonatal dendritic cells are fully competent in processing and presenting antigens via the MHC class I pathway.
Supporting Evidence
- Neonatal dendritic cells showed no defect in presenting MHC class I-restricted antigens.
- The study used multiple assays to evaluate the functionality of neonatal dendritic cells.
- Neonatal dendritic cells were found to be equivalent to adult dendritic cells in cross-presentation capabilities.
Takeaway
This study found that baby immune cells can do their job just as well as adult immune cells when it comes to processing and presenting important signals to fight infections.
Methodology
The study compared the ability of neonatal and adult dendritic cells to present antigens using various assays with CD8+ T cell clones.
Limitations
The study could not directly assess the function of neonatal dendritic cells ex vivo due to limited cell availability.
Participant Demographics
Participants included healthy full-term neonates and normal adult donors.
Statistical Information
P-Value
p=0.9882, p=0.7943, p=0.6489, p=0.8587
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website